Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119130) titled 'Tirofiban for the Prevention of New Ischemic Brain Lesions After Intracranial Angioplasty and Stenting: A Randomized Controlled Study' on Feb. 24.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Huashan Hospital, Fudan University
Condition:
Symptomatic intracranial arterial stenosis
Intervention:
Tirofiban group:Postoperatively, Tirofiban will be administered immediately at 0.2 µg/kg/min for 30 minutes, followed by a maintenance infusion of 0.05 µg/kg/min for 11.5 hours, in addition to standard postoperative medical therapy.
Recruitment Status: Recruiting
Phase: 1
D...